acquired
Stage
About
DVS Sciences developed mass cytometry (CyTOF) instruments and associated reagents for high-dimensional, single-cell protein analysis using time-of-flight mass spectrometry. The company's technology enabled multiplexed single-cell proteomics for research applications and was later acquired and integrated into broader single-cell instrumentation offerings.
Explore DVS Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.